Plasmacytoid Variant of Urothelial Carcinoma: Poor Prognostic Variant with High Expression of CDH1 Mutation
Uro · 2021
DOI: 10.3390/uro1010004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Uro, 2021. Verfasst von Alisa Erck und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Plasmacytoid variant of urothelial carcinoma is a rare subtype of urothelial carcinoma that has poor prognosis. We describe two cases of patients with the plasmacytoid variant of urothelial carcinoma (PVUC) who had initial response to neoadjuvant chemotherapy followed by radical cystoprostatectomy and lymph node dissection but presented with early relapse and disease progression manifesting with intestinal obstruction and peritoneal carcinomatosis. Tumor genomic sequencing revealed mutations and alterations in ARID1A, CDH1, PIK3CA, RB1 loss, and TERT promoter, as well as tumor mutational burden of 10 Muts/Mb treated with pembrolizumab with a minimal response. A further review of the literature regarding this rare variant is discussed here.
Zitieren
APA
Erck, A., Li, W., Movahedi-Lankarani, S., Chung, S., & Aragon-Ching, J. B. (2021). Plasmacytoid Variant of Urothelial Carcinoma: Poor Prognostic Variant with High Expression of CDH1 Mutation. Uro. https://doi.org/10.3390/uro1010004
Vancouver
Erck A, Li W, Movahedi-Lankarani S, Chung S, Aragon-Ching JB. Plasmacytoid Variant of Urothelial Carcinoma: Poor Prognostic Variant with High Expression of CDH1 Mutation. Uro. 2021. doi:10.3390/uro1010004
BibTeX
@article{Erck2021,
author = {Erck, Alisa and Li, Wenping and Movahedi-Lankarani, Saeid and Chung, Simon and Aragon-Ching, Jeanny B.},
title = {Plasmacytoid Variant of Urothelial Carcinoma: Poor Prognostic Variant with High Expression of CDH1 Mutation},
journal = {Uro},
year = {2021},
doi = {10.3390/uro1010004}
}
EUVIMED